Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CardioComm Solutions Inc V.EKG

Alternate Symbol(s):  EKGGF

CardioComm Solutions, Inc. is a global medical provider of consumer heart monitoring and medical electrocardiogram (ECG) software solutions. The Company’s technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. It develops advanced software, hardware and core laboratory reading services related to ECG and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians. The Company is also engaged in manufacturing, marketing, and sales of personal ECG monitors direct to consumers. The products are marketed under the HeartCheck brand. It has developed compatibility of the HeartCheck device to its GEMS and GlobalCardio based software to enable use of the device for remote ECG/arrhythmia monitoring services.


TSXV:EKG - Post by User

Bullboard Posts
Post by eyewatchjbon Jul 10, 2014 2:22pm
323 Views
Post# 22733953

anyone see this news and if you did what do y think

anyone see this news and if you did what do y think
CardioComm amendment to agreement with MD Primer 2014-07-04 16:25 ET - Miscellaneous The TSX Venture Exchange has accepted for filing an amending agreement dated May 7, 2014, which amends the software and source code licensing agreement dated Jan. 20, 2014, between CardioComm Solutions Inc. and MD Primer Inc. as amended on Feb. 7, 2014. Pursuant to the terms of the amending agreement, the second and third payments by MD Primer to the company have been modified to reflect the GEMS WIN software release schedule and associates the second $150,000 milestone payment with the commercial release of GEMS WIN and the third and final $100,000 milestone payment with the commercial release of a GEMS 4.0 software upgrade release. The amending agreement states that if CardioComm fails to complete or elects not to complete GEMS WIN or GEMS 4.0, MD Primer will be permitted to acquire the unfinished software works without restriction and the company's right to repurchase the software licence pursuant to the terms of the SLA will be terminated, subject to disinterested shareholders' approval to the amending agreement. eyewatch
Bullboard Posts